Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision banner updated from v3.6.2 to v3.6.3, indicating a minor internal update to the study page. It does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-03T22:09:32.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 on the page, representing a small software revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:53:29.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Enrollment is no longer open to participants, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:40:38.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. No study details, eligibility criteria, or locations were changed.
    Difference
    0.1%
    Check dated 2026-06-05T13:11:16.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor site update.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:32.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s release rather than any study-specific information.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:44.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.